This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Sleep Apnea Diagnostic And Therapeutic Devices Industry


Resmed and Respironics Dominate Competitive Landscape II-7

Table 1: Global Sleep Apnea Market by Leading Players (2011):

Market Share Breakdown for Philips Respironics, Resmed,

Fisher & Paykel, General Electric Vital Signs, and Others

(includes corresponding Graph/Chart) II-7

Table 2: Global Sleep Apnea Diagnostic Systems Market byLeading Players: Market Share Breakdown for CareFusion Corp.,Philips Respironics, Embla Systems, and Others (includescorresponding Graph/Chart) II-7


Significance of Sleep II-8

Stages of Sleep II-8

Sleep Disorders and Stages of Sleep II-8

Sleep Apnea- Introduction II-8

Forms of Apnea II-9

Central Sleep Apnea II-9

Physiological Effects of CSA II-9

Mixed Apnea II-9

Complex Sleep Apnea II-9

Obstructive Sleep Apnea - An Overview II-10

History II-10

Causes of OSA II-10

Symptoms of OSA II-11

Snoring and OSA II-11

Risks and Complications Associated with Untreated Disorder II-11

Risk Groups II-11

Co-Morbid Conditions II-12

Heart Failure II-12

Hypertension II-12

Diabetes II-12

Fatigue II-12

Complications Associated with Surgery and Medications II-12

Financial Implications of Untreated OSA II-13

Pediatric OSA II-13

5. SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC DEVICES II-14OSA Diagnosis II-14Interpreting AHI II-14AHI of 5 to 15: Mild OSA II-14AHI of 15 to 30: Moderate OSA II-14AHI of more than 30: Severe OSA II-14Sleep Apnea Diagnostic Devices II-14Polysomnography (PSG), and Types of Polysomnographs II-14Clinical/Fixed Polysomnographs II-15Ambulatory Polysomnographs II-15Other Sleep Apnea Diagnostic Devices II-16Screening Devices II-16Actigraphs II-16Sleep Apnea Therapeutic Devices II-16Positive Airway Pressure (PAP) Treatment II-16PAP Devices II-16Continuous Positive Airway Pressure (CPAP) Devices II-16Optional Features Available for CPAP Devices II-17Bilevel Positive Airway Pressure (BiPAP) Devices II-17Auto-titrating Positive Airway Pressure (APAP) Devices II-18Facial Interfaces (Masks and Humidifiers) II-18Alternative Apnea Therapies II-18Oral Appliances II-18Surgical Procedures II-19Tracheostomy II-19Uvulo-palato-pharyngoplasty (UPPP) II-19Mandibular Myotomy II-19Laser Assisted Uvuloplasty (LAUP) II-19Somnoplasty or Radio Frequency (RF) Procedure II-19Pillar Palatal Implant System II-20Other Surgical Therapies II-20Over-the-Counter and Pharmacological Therapies II-20Behavioral and Lifestyle Changes II-20

2 of 16

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.99 0.00%
FB $102.01 0.00%
GOOG $682.40 0.00%
TSLA $151.04 0.00%
YHOO $27.04 0.00%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs